Stay updated on Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial

Sign up to get notified when there's something new on the Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2 on the page; this is a minor system update and does not affect the study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T19:06:49.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Removed the generic government funding/status notice from the page; core study details and eligibility criteria remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T18:11:17.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    No significant changes detected on the Study Details page between the two screenshots.
    Difference
    0.5%
    Check dated 2025-11-03T12:48:46.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    - Updated the page to v3.2.0 and added a government-operational status notice clarifying potential delays and open status of NIH Clinical Center. - Removed the previous version tag v3.1.0.
    Difference
    4%
    Check dated 2025-10-05T17:30:22.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Page version updated from v3.0.2 to v3.1.0 with an added contact-like string (+86-571-87235147); no changes to core content, pricing, or availability inferred.
    Difference
    0.1%
    Check dated 2025-09-28T10:43:19.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Core change: Revision updated to v3.0.2 (replacing v3.0.1). Minor UI change: the 'Back to Top' link was removed.
    Difference
    0.3%
    Check dated 2025-09-14T00:33:55.000Z thumbnail image

Stay in the know with updates to Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial page.